Lind Global Asset Management XII

Lind Global Asset Management XII is a specialized investment vehicle managed by The Lind Partners, a New York-based institutional fund manager. The entity provides growth capital to small- and mid-cap public companies across various sectors, with a significant focus on life sciences, biotechnology, and healthcare. Lind typically utilizes structured investment instruments such as convertible securities, equity-linked loans, and follow-on equity placements to support clinical development and corporate operations. While it is a frequent financier for biotech firms, it is an investment entity rather than a drug development company and does not maintain its own therapeutic pipeline.